Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · IEX Real-Time Price · USD
5.16
-0.10 (-1.90%)
At close: Jul 19, 2024, 4:00 PM
5.21
+0.05 (0.97%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

Prelude Therapeutics Statistics

Total Valuation

PRLD has a market cap or net worth of $283.44 million. The enterprise value is $95.11 million.

Market Cap 283.44M
Enterprise Value 95.11M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date Aug 1, 2024
Ex-Dividend Date n/a

Share Statistics

PRLD has 54.93 million shares outstanding. The number of shares has increased by 58.65% in one year.

Shares Outstanding 54.93M
Shares Change (YoY) +58.65%
Shares Change (QoQ) +8.83%
Owned by Insiders (%) 9.09%
Owned by Institutions (%) 81.51%
Float 13.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.35
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.64, with a Debt / Equity ratio of 0.08.

Current Ratio 11.64
Quick Ratio n/a
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -53.00% and return on invested capital (ROIC) is -60.21%.

Return on Equity (ROE) -53.00%
Return on Assets (ROA) -47.20%
Return on Capital (ROIC) -60.21%
Revenue Per Employee n/a
Profits Per Employee -$980,820
Employee Count 128
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +7.72% in the last 52 weeks. The beta is 1.54, so PRLD's price volatility has been higher than the market average.

Beta (5Y) 1.54
52-Week Price Change +7.72%
50-Day Moving Average 4.03
200-Day Moving Average 3.73
Relative Strength Index (RSI) 61.09
Average Volume (20 Days) 151,771

Short Selling Information

The latest short interest is 559,805, so 1.02% of the outstanding shares have been sold short.

Short Interest 559,805
Short Previous Month 566,883
Short % of Shares Out 1.02%
Short % of Float 4.10%
Short Ratio (days to cover) 10.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -137.51M
Pretax Income -125.55M
Net Income -125.55M
EBITDA -122.31M
EBIT -125.55M
Earnings Per Share (EPS) -$1.88
Full Income Statement

Balance Sheet

The company has $205.97 million in cash and $17.64 million in debt, giving a net cash position of $188.33 million or $3.43 per share.

Cash & Cash Equivalents 205.97M
Total Debt 17.64M
Net Cash 188.33M
Net Cash Per Share $3.43
Equity (Book Value) 210.73M
Book Value Per Share 3.84
Working Capital 187.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$108.72 million and capital expenditures -$2.99 million, giving a free cash flow of -$111.71 million.

Operating Cash Flow -108.72M
Capital Expenditures -2.99M
Free Cash Flow -111.71M
FCF Per Share -$1.48
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PRLD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -58.65%
Shareholder Yield -58.65%
Earnings Yield -44.29%
FCF Yield -39.41%

Analyst Forecast

The average price target for PRLD is $5.25, which is 1.74% higher than the current price. The consensus rating is "Hold".

Price Target $5.25
Price Target Difference 1.74%
Analyst Consensus Hold
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -8.94%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2